Camelot Portfolios, LLC Merck & Co., Inc. Transaction History

Camelot Portfolios, LLC

$179 Million
Q2 2024

A detailed history of Camelot Portfolios, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Camelot Portfolios, LLC holds 553 shares of MRK stock, worth $56,339. This represents 0.04% of its overall portfolio holdings.

Number of Shares

553

Holding current value

$56,339

% of portfolio

0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $68,461 - $73,526	553 New	553 $68,000
Q4 2023 Jan 23, 2024	BUY	$100.18 - $109.02 $188,739 - $205,393	1,884 New	1,884 $205,000
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $190,284 - $207,401	-1,752 Reduced 37.33%	2,941 $339,000
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $6,279 - $7,006	61 Added 1.32%	4,693 $499,000
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $94,959 - $121,751	1,086 Added 30.63%	4,632 $0
Q3 2022 Oct 31, 2022	SELL	$84.53 - $94.96 $267,114 - $300,073	-3,160 Reduced 47.12%	3,546 $305,000
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $108,620 - $123,126	-1,301 Reduced 16.25%	6,706 $611,000
Q1 2022 Apr 20, 2022	SELL	$73.51 - $82.4 $282,057 - $316,168	-3,837 Reduced 32.4%	8,007 $657,000
Q4 2021 Jan 04, 2022	BUY	$72.28 - $90.54 $307,190 - $384,795	4,250 Added 55.97%	11,844 $908,000
Q3 2021 Nov 04, 2021	SELL	$71.68 - $78.83 $251,883 - $277,008	-3,514 Reduced 31.63%	7,594 $570,000
Q2 2021 Jul 28, 2021	SELL	$70.31 - $77.77 $37,193 - $41,140	-529 Reduced 4.55%	11,108 $864,000
Q1 2021 Apr 21, 2021	BUY	$68.86 - $81.11 $382,241 - $450,241	5,551 Added 91.21%	11,637 $897,000
Q4 2020 Jan 27, 2021	BUY	$71.77 - $79.65 $436,792 - $484,749	6,086 New	6,086 $498,000
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $210,712 - $251,614	-4,082 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $239,490 - $257,696	4,082	4,082 $261,000

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.

Account

Camelot Portfolios, LLC Merck & Co., Inc. Transaction History